A detailed history of Prudential Financial Inc transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 3,655 shares of MDGL stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,655
Previous 1,373 166.21%
Holding current value
$1.23 Million
Previous $291,000 287.29%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 11, 2025

BUY
$202.45 - $354.85 $461,990 - $809,767
2,282 Added 166.21%
3,655 $1.13 Million
Q3 2024

Nov 13, 2024

BUY
$212.22 - $292.96 $10,823 - $14,940
51 Added 3.86%
1,373 $291,000
Q2 2024

Aug 13, 2024

BUY
$193.33 - $291.99 $39,245 - $59,273
203 Added 18.14%
1,322 $370,000
Q1 2024

May 14, 2024

SELL
$171.37 - $283.23 $171 - $283
-1 Reduced 0.09%
1,119 $298,000
Q4 2023

Feb 13, 2024

BUY
$120.4 - $237.13 $134,848 - $265,585
1,120 New
1,120 $259,000
Q2 2023

Aug 11, 2023

SELL
$203.88 - $312.0 $1.02 Million - $1.56 Million
-5,008 Reduced 82.82%
1,039 $240,000
Q1 2023

May 12, 2023

SELL
$231.06 - $307.08 $1.63 Million - $2.16 Million
-7,047 Reduced 53.82%
6,047 $1.46 Million
Q4 2022

Feb 14, 2023

SELL
$58.39 - $296.54 $452,814 - $2.3 Million
-7,755 Reduced 37.2%
13,094 $0
Q3 2022

Nov 04, 2022

BUY
$60.57 - $79.51 $3,028 - $3,975
50 Added 0.24%
20,849 $1.36 Million
Q2 2022

Aug 15, 2022

BUY
$58.04 - $100.2 $574,886 - $992,481
9,905 Added 90.92%
20,799 $1.49 Million
Q2 2020

Aug 12, 2020

BUY
$60.13 - $125.71 $1,202 - $2,514
20 Added 0.18%
10,894 $1.23 Million
Q1 2020

May 12, 2020

SELL
$66.76 - $93.49 $5,073 - $7,105
-76 Reduced 0.69%
10,874 $725,000
Q4 2019

Feb 11, 2020

BUY
$84.28 - $118.5 $835,214 - $1.17 Million
9,910 Added 952.88%
10,950 $997,000
Q3 2018

Nov 07, 2018

BUY
$207.3 - $300.31 $43,533 - $63,065
210 Added 25.3%
1,040 $0
Q2 2018

Aug 13, 2018

BUY
$101.55 - $313.9 $84,286 - $260,536
830 New
830 $0

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.75B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.